METHOCEL™ Premium CR Cellulose Ethers

First choice for the formulation of hydrophilic matrix systems, providing a robust mechanism for the extended/controlled release of drugs from oral solid dosage forms. With a choice of viscosity grades METHOCEL™ premium cellulose ethers provide a simple solution to meet a range of drug solubility needs. Tablets are easily manufactured with existing, conventional equipment and processing methods.

Matrix Tablet Formulations

Now available as directly compressible grades, METHOCEL™ DC2 polymers deliver exceptional flow properties and process capability as well as consistent modified release performance for matrix formulations. METHOCEL™ DC2 will enable manufacturers to replace costly wet granulation in matrix tablet production with cost effective dry granulation and direct compression techniques.

Three direct compression grades of METHOCEL™ DC2 are now available: K100 LV, K4M and K100M; chemically identical to current METHOCEL™ Premium products and meet USP, PhEur and JP specifications.

Colorcon, through the Controlled Release Alliance, has exclusive, global sales and distribution rights for METHOCEL™ products from IFF for use in controlled release applications.

_{METHOCEL™ is a trademark of International Flavors and Fragrances Inc. or its affiliates.  © 2021 IFF.  All rights reserved}